Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery

por Rubio-Herrera, Miguel A., Mera-Carreiro, Sara, Sánchez-Pernaute, Andrés, Ramos-Levi, Ana M.
Publicado 2023

Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors

por Sebastian-Valles, Fernando, Bernaldo Madrid, Blanca, Sager, Carolina, Carrillo López, Elena, Mera Carreiro, Sara, Ávila Antón, Laura, García, Noelia Sánchez-Maroto, Sampedro-Nuñez, Miguel Antonio, Pérez, Jose Ángel Díaz, Marazuela, Mónica
Publicado 2023